Brandsymbol

Business is built on RELATIONSHIPS. 🤝 One of my biggest priorities this year is strengthening client engagement—because great work isn’t just about delivering results, it’s about building trust, alignment, and long-term partnerships. Here’s how we’re kicking off the year: ✔️ Aligning with clients on their evolving goals ✔️ Adding value beyond the status quo in brand creation ✔️ Keeping communication transparent, strategic, and solution-driven The best partnerships aren’t just transactional—they’re built on collaboration, trust, and shared success. 🎯 How are you strengthening relationships with your clients this year? I’d love to hear your approach! 🔹 Follow: Emilie Tolley 🔹 Follow: Brandsymbol #ClientEngagement #RelationshipsMatter #BusinessGrowth #StrategicPartnerships

📢 The European Shortages Monitoring Platform #ESMP is now fully live!   Marketing authorisation holders and national competent authorities can now directly report information on supply, demand and availability of medicines to the platform 📅 This will become mandatory as of 2 February 2025.   Having the data available will speed up Europe’s ability to put in place coordination actions to prevent and mitigate medicine shortages.   Get prepared to use ESMP! EMA offers webinars and guidance materials to get started on the platform.   Learn more about ESMP ➡️ https://lnkd.in/dB5Xh4X2

This latest press briefing highlights the EMA's dedication to advancing treatments while safeguarding public health. 🌍💊 As a naming agency specializing in unforgettable, globally resonant pharmaceutical and healthcare brands, we stay attuned to updates from regulatory bodies like the EMA. These insights empower us to craft names that not only meet linguistic and cultural standards but also align seamlessly with legal and regulatory requirements across markets. We’re inspired by the EMA’s commitment to improving health outcomes, and we’re proud to support the industry in bringing life-changing innovations to patients worldwide. Follow: Clayton T. Follow: Brandsymbol #Pharma #BrandNaming #EMA #RegulatoryExcellence #HealthcareInnovation

This two-day event, #APhA2025 Day of Science on March 21-22, will connect you with researchers and thought leaders shaping the future of pharmacy.     Highlights include:  ➡️Keynote Session: Insights into technological automation and its impact on pharmacy outcomes  ➡️Interactive Poster Forums: Explore groundbreaking research and connect with investigators  ➡️Author Workshop: Learn practical steps for publishing your research and contributing as a peer reviewer    Whether you're a researcher, practitioner, or student, this is your chance to gain actionable insights and make meaningful connections.    Register now! https://ow.ly/PrQE50UMzXe

Necesitas saberlo si te planteas el lanzamiento de una marca en el mercado chino.

Just One Month Left Until the Deadline for the April NRG meeting! Some Important Dates: Submission Deadline: February 28th, 2025 NRG Meeting/Discussion: April 8th-9th, 2025 CHMP Adoption (Expected): May 22nd, 2025 If you have any questions, need assistance, or if Brandsymbol can support you in any way to get you the best name possible, please don't hesitate to reach out.:https://lnkd.in/e4AZsipB #Brandsymbol #branding #naming #NRG #CHMP #SubmissionDeadline

💡 Did you know? The EMA Name Review Group (NRG) rejected 38% of names submitted in 2024. That’s a staggering statistic for pharmaceutical companies trying to get their emerging assets to market. Navigating the EMA approval process can be complex and challenging, and even the smallest oversight in your naming strategy can result in costly delays. 🔗 Overview of Invented Names Reviewed in 2024: https://lnkd.in/eNCdf4Vg. Don’t let your asset become part of next year’s rejection statistic. Let’s connect to ensure your naming strategy clears every hurdle for 2025. https://lnkd.in/eHQb9zE6. Follow: Emilie Tolley Follow: Brandsymbol #PharmaceuticalNaming #EMAApproval #RegulatoryStrategy

✨ In 2024, EMA recommended 2️⃣5️⃣ #veterinary #medicines for marketing authorisation – the highest ever number of recommendations in a year. ✨ Of these, two had a new active substance, which had not previously been authorised in veterinary medicine in the EU. 💉 Among the medicines recommended for marketing authorisation in 2024, 1️⃣4️⃣ were vaccines, including seven that had been developed by means of a biotechnological process. An overview of the Agency’s key recommendations on the authorisation and safety monitoring of veterinary medicines is now available ⬇️

Congratulations to our partners at Alexion on the launch of their new clinical trial, I CAN. I CAN investigates the safety and effectiveness of a medication aimed at managing symptoms in adults with immunoglobulin A nephropathy (IgAN): https://lnkd.in/epmfjGmH Want to learn more about our latest work? Click here: https://lnkd.in/eRdazX8X #Brandsymbol #branding #naming #IgANephropathy